BioSpace News Archive

Genetown

Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024

Atea Pharmaceuticals, Inc. today announced the presentation of Phase 1 data highlighting the safety profile of bemnifosbuvir, an oral nucleotide polymerase inhibitor, at the European Society of Clinical Microbiology & Infectious Diseases Global 2024.

April 29, 2024
·
7 min read
Business

FibroGen to Report First Quarter 2024 Financial Results

FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial results on Monday, May 6 after the market close.

April 29, 2024
·
1 min read
Genetown

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Prime Medicine, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for PM359, submitted on March 29.

April 29, 2024
·
7 min read
Business

Kraig Biocraft Laboratories Reports Signing Landmark Agreements in South East Asia

Kraig Biocraft Laboratories, Inc., announces that it has signed key agreements with the Lam Dong Agro-Forestry Research Experiment Center, the sericulture authority in central Vietnam, pertaining to the rearing and breeding of the Company’s specialized silkworm.

April 29, 2024
·
3 min read
Business

Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2024 financial results on Thursday, May 2, 2024 after the markets close.

April 29, 2024
·
3 min read
Business

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC

Bio-Techne Corporation is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers.

April 29, 2024
·
4 min read
Business

WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and life sciences industry, announced its financial results for the first quarter ending March 31, 2024.

April 29, 2024
·
18 min read
Lone Star Bio

Nanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation Summits

Nanoscope Therapeutics Inc. today announced that Samarendra Mohanty , PhD, Co-Founder, and President, will present in the Retinal Cell and Gene Therapy Innovation Summit 2024.

April 29, 2024
·
2 min read
FDA

Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer’s Newly Approved Gene Therapy to Treat Patients with Hemophilia B

Labcorp today announced the U.S. Food and Drug Administration (FDA) has approved its nAbCyte™ Anti-AAVRh74var HB-FE Assay, a companion diagnostic (CDx) to determine patient eligibility for treatment with BEQVEZ™ (fidanacogene elaparvovec-dzkt), Pfizer’s recently FDA-approved hemophilia B gene therapy.

April 29, 2024
·
3 min read
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

Bausch + Lomb Corporation today announced the presentation of 21 scientific poster presentations during the Association for Research in Vision and Ophthalmology Annual Meeting, which will take place in Seattle May 5-9, 2024.

April 29, 2024
·
5 min read